Recap: Bio-Rad Laboratories Q4 Earnings

Bio-Rad Laboratories BIO reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Bio-Rad Laboratories beat estimated earnings by 12.63%, reporting an EPS of $3.21 versus an estimate of $2.85.

Revenue was up $57.07 million from the same period last year.

Last quarter the company beat on EPS by $1.27, which was followed by a 0.74% increase in the share price the next day.

Here's a look at Bio-Rad Laboratories's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	2.44	2.66	3	3.29
EPS Actual	3.71	3.54	5.21	4.01
Revenue Estimate	661.87M	631.78M	660.98M	686.80M
Revenue Actual	715.20M	715.93M	726.80M	789.84M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.